Biogen backing Ontogeny's "hedgehog" proteins CNS research with up to $80 mil.
BIOGEN/ONTOGENY TO DEVELOP "HEDGEHOG" CELL DIFFERENTIATION PROTEINS FOR CNS disorders, including Parkinson's disease and amyotrophic lateral sclerosis, the companies jointly announced July 19. Privately-held Ontogeny has identified a family of "hedgehog" proteins responsible for the formation and regeneration of tissues -- the Sonic, Indian and Desert "hedgehogs," the companies stated.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth